Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

‘We’ve Moved the Needle Quite Far’ in Management of Crohn Disease

Dr. Rubin discusses how the management of Crohn disease has changed over time, the importance of understanding the disease for proper management, and common mistakes in treatment that remain.

Endoscopic Phenotype: A Potential Predictor of Cuffitis Risk

Advanced IBD Fellow Shintaro Akiyama, MD, PhD presented a Quick Shot of his abstract on pouchitis involving the rectal cuff at Crohn's and Colitis Congress. MedPage Today reported the results in the article here and Healio reported the results here. Very proud of Dr....

Newly Discovered Vascular Barrier in the Brain May Explain IBD-Related Anxiety, Depression

A newly discovered vascular brain barrier that blocks the passage of inflammatory molecules triggered by gut bacteria may be why patients with inflammatory bowel disease (IBD) are at increased risk for certain mental health disorders, including anxiety and depression,...

Dr. David T. Rubin Guest-Hosts IBD Drive Time

Take a listen to Dr. Rubin discuss the impact of inflammatory bowel disease on sexual function with University of Chicago's GI psychologist, Dr. Alyse Bedell, and pelvic floor physical therapist, Sarah Macaraeg.

Special Edition VGR: COVID-19 Vaccine Update

Click here to watch Dr. David Rubin and his colleagues explain the data behind the various vaccines, clinical recommendations, allergy and safety recommendation, and describe COVID-19 vaccine special issues in underrepresented minorities.

Hospital-stay duration after IBD surgery not linked to sleep, activity

Second-year Pritzker medical student, Yangtian Yi, received Best Abstract in Surgery at AIBD 2019 for his abstract associating length of stay for IBD surgical patients with data collected from wearable devices. His oral presentation and abstract was reported on by...

Dr. Rubin Moderates “Getting It Right: How to Manage Nutrient Deficiencies in IBD”

Available here by logging on to your Medscape education account, join Dr. Rubin and panelists Dr. Jason Hou, Dr. Raluca Vrabie, and Kelly Issokson discuss management of nutrient deficiencies in IBD patients.

Dr. David T. Rubin on Bowel Urgency: the Next Frontier in Management of Ulcerative Colitis

Listen here as Professor David T. Rubin discusses bowel urgency in ulcerative colitis and its management with Professor Laurent Peyrin-Biroulet in a recent episode of IBDscope.

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...